Evidence map›Paper›PMID 28010520›Full record

ArticleHuman vaccines & immunotherapeutics2016

Innovation, urgency and acceptance at the 9th Vaccine Renaissance.

Anne S De Groot, Lenny Moise

Abstract readConference Proceedings
In one paragraph

Article in Human vaccines & immunotherapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anne S De Groota EpiVax, Inc. , Providence , RI , USA ; Institute for Immunology and Informatics, College of the Environment and Life Sciences, University of Rhode Island , Providence , RI , USA.
Lenny Moisea EpiVax, Inc. , Providence , RI , USA ; Institute for Immunology and Informatics, College of the Environment and Life Sciences, University of Rhode Island , Providence , RI , USA.

Funding

Vaccine Renaissance Conference at the Institute for Immunology and InformaticsR13AI094946 · NIAID · UNIVERSITY OF RHODE ISLAND · PI DEGROOT, ANNE SEARLS · 2011 to 2018
$61k
NIAID NIH HHS R13 AI094946
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease Transmission, InfectiousHumansVaccinationVaccinesVaccines

Identifiers

PMID28010520
PMCPMC5215550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.